One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others ...

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others ...

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others. A study published in ...

Researchers at the Earlham Institute, the University of Edinburgh and Heriot-Watt University analyzed gut cells to understand ...

Scope-X, an expanded version of the Seq-Scope spatial transcriptomics method. The technique overcomes diffusion limits and ...

As inflamed regions of the gut form scar tissue, the space within the gut lumen becomes smaller and more restricted, leading ...

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

BostonGene, developer of the leading AI foundation model for tumor and the immune biology, today announced it has been honored as the Innovator of the Year at the 2025 Life Sciences Times Vanguard ...

CD4+ T cells, long regarded as supporting actors in cancer immunity, are emerging as central regulators of tumor control and ...

The single-cell genomics industry does not stop advancing, with a steady stream of new companies, kits, acquisitions, and more. One new company, ArgenTag, was founded in Argentina during the COVID-19 ...